LYNDSAY LEIGH REBECCA FUNK

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family SHOW LOW, AZ NPI 1124784657

General Payments — all program years on this page

$1,571.64

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 92
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $384.50 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $384.5022

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $563.6831
2023 $623.4639
2024 $384.5022

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086278116 Bayer Healthcare Pharmaceuticals Inc. $16.44 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087852784 Pulmonx Corporation $16.93 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100244877 Novo Nordisk Inc $22.03 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100468750 Novo Nordisk Inc $19.57 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100520073 Novo Nordisk Inc $20.73 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100628050 Novo Nordisk Inc $13.51 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116039808 GlaxoSmithKline, LLC. $13.87 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116060629 GlaxoSmithKline, LLC. $16.48 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116908229 Medtronic, Inc. $14.36 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117557561 Amgen Inc. $18.13 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117557563 Amgen Inc. $21.53 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130896460 PFIZER INC. $18.18 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130897247 PFIZER INC. $20.22 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130917439 PFIZER INC. $19.44 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130937078 PFIZER INC. $16.28 07/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130954205 PFIZER INC. $15.59 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131008053 PFIZER INC. $17.65 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139480714 Astellas Pharma US Inc $17.73 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139501310 Astellas Pharma US Inc $18.44 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139507061 Astellas Pharma US Inc $15.29 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139539098 Astellas Pharma US Inc $18.50 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145457653 Organogenesis Inc. $13.60 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.